The interdural and transcavernous approach is a safe and effective microsurgical technique for resection of giant cavernous sinus hemangiomas, enabling high rates of total resection with minimal morbidity.
Key Findings
Results
Gross total resection (GTR) was achieved in 80% of patients with giant cavernous sinus hemangiomas using transcavernous microsurgical techniques.
GTR was achieved in 12 of 15 patients (80%)
Near-total resection (NTR) was achieved in 3 of 15 patients (20%)
The study represents one of the large single-center surgical series on CSH utilizing transcavernous microsurgical techniques and interdural splitting
Surgeries were performed between January 2023 and April 2025
Results
Mean intraoperative blood loss was significantly lower in the GTR group compared to the NTR group.
Mean intraoperative blood loss in the GTR group was 1133.3 ± 427.7 mL
Mean intraoperative blood loss in the NTR group was 1766.7 ± 208.2 mL
The difference was statistically significant (P = 0.03)
This finding suggests that cases requiring only NTR may have involved more difficult or vascular tumors
Results
Larger tumor volume positively correlated with higher intraoperative blood loss.
Pearson correlation coefficient r = 0.52
The correlation was statistically significant (P = 0.04)
Despite increased bleeding risk with larger tumors, GTR was still achievable with proper anatomical planning and technique
Results
At 6-month follow-up, 66.7% of patients showed symptomatic improvement.
10 of 15 patients (66.7%) demonstrated symptomatic improvement at 6-month follow-up
Postoperative cranial nerve deficits occurred in 13.3% of patients (n = 2)
There was no mortality in the series
The extent of resection was not significantly associated with short-term functional outcome (P = 0.58)
Results
The extent of resection (GTR vs. NTR) was not significantly associated with short-term neurological outcomes.
No statistically significant association was found between extent of resection and short-term functional outcome (P = 0.58)
This finding supports NTR as a reasonable alternative in select cases without compromising short-term neurological outcomes
The study included qualitative observations from surgeon reflections and operation notes in addition to quantitative data
Methods
The study was a retrospective single-center review of 15 patients with radiologically and histologically confirmed cavernous sinus hemangiomas.
Data analyzed included surgical technique, intraoperative blood loss, tumor volume, clinical presentation, demographics, amount of resection, and complications
Statistical analysis was performed using SPSS 24.0
The study period spanned January 2023 to April 2025
Cavernous sinus hemangiomas are described as uncommon, benign vascular lesions presenting considerable surgical problems due to their location and vascularity
What This Means
This research examines a challenging type of benign brain tumor called a cavernous sinus hemangioma (CSH), which grows in a complex area at the base of the skull called the cavernous sinus — sometimes referred to as 'no man's land' due to the surgical risks involved. The researchers reviewed outcomes from 15 patients who underwent surgery at a single center over approximately two years, using a specialized microsurgical approach that involves carefully splitting layers of tissue to access and remove the tumor. They found that complete tumor removal was achieved in 80% of cases, and that two-thirds of patients showed symptom improvement six months after surgery, with a low rate of new nerve-related complications (13.3%) and no deaths.
The study also found that larger tumors were associated with greater blood loss during surgery, and that cases where only near-total removal was achieved tended to involve more bleeding. However, importantly, whether surgeons achieved complete or near-complete removal did not significantly affect patients' short-term neurological recovery, suggesting that in difficult cases, leaving a small amount of tumor behind may be an acceptable strategy. This research suggests that with careful surgical planning and technique, this highly vascular and anatomically complex tumor can be safely and effectively treated through surgery, even when the tumors are large.
While stereotactic radiosurgery (a non-invasive radiation treatment) is increasingly used for these tumors, this study highlights that surgical removal remains an important option, particularly for larger lesions. The findings contribute to a limited body of literature on this rare tumor type and provide practical guidance — including the surgeons' own qualitative reflections — for neurosurgeons facing these challenging cases.
Srivastava A, Singh S, Bhaisora K, Maurya V, Das K. (2026). Conquer Your Hesitation and Show the Neurosurgeon's Valor in "No Man's Land"! Surgical Tips and Nuances on Giant Cavernous Sinus Hemangioma.. Neurology India. https://doi.org/10.4103/neurol-india.Neurol-India-D-25-01048